Bigul

Chemcrux Enterprises Ltd - 540395 - Disclosure Of Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2022

Please find enclosed disclosure of Related Party Transactions for the half year ended 30th September 2022 pursuant to Regulation 23 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
26-11-2022
Bigul

Chemcrux Enterprises Ltd - 540395 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication of Standalone Unaudited Financial Results for the quarter and half year ended 30th September 2022
14-11-2022
Bigul

Chemcrux Enterprises Ltd - 540395 - Unaudited Standalone Financial Results For The Quarter And Half Year Ended 30Th September 2022

Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we enclose the following: 1. Statement showing the Unaudited Standalone Financial Results for the quarter and half year ended 30th September 2022. 2. Statements of Assets and Liabilities as on 30th September 2022. 3. Cash Flow Statement for the half year ended 30th September 2022. 4. Limited Review Report issued by the Statutory Auditors of the Company.
12-11-2022
Bigul

Chemcrux Enterprises Ltd - 540395 - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th November 2022

The Board of Directors of the Company at their meeting held today i.e., Saturday, 12th November 2022 at the Registered Office of the Company located at 330, Trivia Complex, Natubhai Circle, Racecourse, Vadodara- 390007, Gujarat; inter alia: Considered and approved the Unaudited Standalone Financial Results for the 2nd quarter and Half Year ended 30th September 2022 of the FY 2022-23 as reviewed and recommended by the Audit Committee along with Limited Review Report issued by Statutory Auditors of the Company, R. J. Shah & Associates, Chartered Accountants.
12-11-2022
Bigul

Chemcrux Enterprises Ltd - 540395 - Board Meeting Intimation for Unaudited Standalone Financial Results For The 2Nd Quarter And Half Year Ended On 30Th September 2022

Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 ,inter alia, to consider and approve Unaudited Standalone Financial Results for the 2nd quarter and half year ended on 30th September 2022 for the FY 2022-23 and other related matters thereto.
05-11-2022
Bigul

Chemcrux Enterprises Ltd - 540395 - Statement Of Investor Complaints For The Quarter Ended September 2022

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dipika RajpalDesignation :- Company Secretary and Compliance Officer
08-10-2022
Bigul

Chemcrux Enterprises Ltd - 540395 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2022
08-10-2022
Bigul

Chemcrux Enterprises Ltd - 540395 - Closure of Trading Window

Intimation of Closure of Trading Window
30-09-2022
Bigul

Chemcrux Enterprises Ltd - 540395 - Announcement under Regulation 30 (LODR)-Change in Directorate

Members of the Company in the 26th Annual General Meeting of the Company held on 23rd September 2022, have approved through special resolution, Regularisation of Mr. Mukund Prahlad Bakshi (DIN: 00066993) as an Independent Director for a tenure of 5 years with effect from 22nd December, 2021.
24-09-2022
Bigul

Chemcrux Enterprises Ltd - 540395 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Pursuant to Regulation 44, attached herewith is Voting Results along with Scrutinizers Report on the remote e-voting and e-voting at the 26th Annual General Meeting of Company.
24-09-2022
Next Page
Close

Let's Open Free Demat Account